39.74
-0.44
(-1.10%)
As of 12:31:13 PM GMT+1. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 6 | 4 | 11 | 11 |
Avg. Estimate | 1.02 | 0.86 | 2.94 | 3.56 |
Low Estimate | 0.84 | 0.77 | 2.74 | 2.4 |
High Estimate | 1.13 | 1.01 | 3.07 | 4.22 |
Year Ago EPS | 0.46 | 0.51 | 1.49 | 2.94 |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 11 | 11 |
Avg. Estimate | 4.09B | 4.2B | 17.05B | 17.91B |
Low Estimate | 4.09B | 4.2B | 16.14B | 15.51B |
High Estimate | 4.09B | 4.2B | 18.47B | 20.78B |
Year Ago Sales | 3.67B | 3.52B | 10.95B | 17.05B |
Sales Growth (year/est) | 11.50% | 19.50% | 55.70% | 5.00% |
Earnings History
Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
---|---|---|---|---|
EPS Est. | 0.46 | 0.34 | 0.59 | 0.81 |
EPS Actual | 0.46 | 0.51 | 0.65 | 0.76 |
Difference | 0 | 0.17 | 0.06 | -0.05 |
Surprise % | 0.00% | 50.00% | 10.20% | -6.20% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 1.02 | 0.86 | 2.94 | 3.56 |
7 Days Ago | 1.01 | 0.85 | 2.9 | 3.51 |
30 Days Ago | 0.94 | 0.92 | 2.76 | 3.46 |
60 Days Ago | 0.86 | 0.76 | 2.67 | 3.21 |
90 Days Ago | 0.86 | 0.75 | 2.66 | 3.19 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | 3 | -- | 5 | 4 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
NMM.DU | 121.70% | 68.60% | 97.30% | 21.10% |
S&P 500 | 9.90% | 11.00% | 14.01% | 13.54% |
Upgrades & Downgrades
Maintains | Scotiabank: Sector Perform to Sector Perform | 1/21/2025 |
Initiated | CLSA: Underperform | 11/29/2024 |
Maintains | Raymond James: Outperform to Outperform | 11/25/2024 |
Upgrade | JP Morgan: Neutral to Overweight | 11/19/2024 |
Downgrade | UBS: Buy to Neutral | 10/30/2024 |
Maintains | Raymond James: Outperform to Outperform | 10/25/2024 |